Actionable news
0
All posts from Actionable news
Actionable news in AKBA: AKEBIA THERAPEUTICS Inc,

Akebia Announces Presentations at the Upcoming American Society of Nephrology Kidney Week 2015 Annual Meeting

CAMBRIDGE, Mass., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Akebia Therapeutics, Inc. (AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that data from the vadadustat (formerly AKB-6548) development program will be presented at the upcoming American Society of Nephrology (ASN) Kidney Week 2015 annual meeting in San Diego, California from November 3-8, 2015.

Late-Breaker Poster Presentation:


Saturday, November 7, 2015, 10:00 AM - 12:00 PM
Title: Vadadustat, a Novel Oral Treatment for Anemia of Chronic Kidney Disease, Maintains Stable Hemoglobin Levels in Dialysis Patient Converting from Erythropoiesis-Stimulating Agents (Abstract Program #SA-PO1110)
Session Title: Late-Breaking Clinical Trial Posters
Location: Exhibit Hall


Oral Presentation:


Thursday, November 5, 2015, 4:30 PM - 6:30 PM, Presentation 5:54 PM
Title:
Hemoglobin (Hb) Response in a Phase 2b Study of AKB-6548 for the Treatment of Anemia in Patients with Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) (Abstract Program #TH-OR038)
Session Title: Clinical Trials in CKD: Pursuing a New Horizon
Location: Room 25
Poster Sessions:


Thursday, November 5, 2015, 10:00 AM - 12:00 PM
Title:
Vadadustat Demonstrates Controlled Hemoglobin Response in a Phase 2b Study for the Treatment of Anemia in Patients with Non-Dialysis Dependent Chronic Kidney Disease (Abstract Program #TH-PO649)
Session Title: CKD: Clinical Trials
Location: Exhibit Hall


Saturday, November 7, 2015, 10:00 AM - 12:00 PM
Title: Dose Exposure Relationship of Vadadustat is Independent of the Level of Renal Function (Abstract Program #SA-PO537)
Session Title: Drug Pharmacokinetics and Pharmacogenomics in CKD
Location: Exhibit Hall

Collaborative Poster Session Details:


Thursday, November 5, 2015, 10:00 AM - 12:00 PM
Title: The Effect of Altitude on Erythropoiesis-Stimulating Agent Dose, Hemoglobin Level, and Mortality in Hemodialysis Patients (Abstract Program #TH-PO936)
Session Title: Dialysis: Epidemiology, Outcomes, and Clinical Trials: Noncardiovascular - I
Location: Exhibit Hall
Collaboration with Davita Clinical Research


Saturday, November 7, 2015, 10:00 AM - 12:00 PM
Title:
...

More